Johnson, Scott M. https://orcid.org/0000-0001-7912-349X
Bao, Hanmei
McMahon, Cailin E.
Chen, Yongbin https://orcid.org/0000-0001-9359-6525
Burr, Stephanie D. https://orcid.org/0000-0002-8832-8128
Anderson, Aaron M. https://orcid.org/0000-0003-1797-5229
Madeyski-Bengtson, Katja
Lindén, Daniel https://orcid.org/0000-0003-4158-8018
Han, Xianlin https://orcid.org/0000-0002-8615-2413
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK089178, DK109096, DK124190, DK124190)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Mayo Graduate School of Biomedical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 1 November 2023
Accepted: 22 May 2024
First Online: 6 June 2024
Competing interests
: KM-B and DL are employed by and have shares in AstraZeneca. The remaining authors declare no competing interests.